Prof. Sarah Coupland is a senior pathologist at the Royal Liverpool University Hospital (RLBUHT) and the George Holt Chair of Pathology at the University of Liverpool (UoL). She is lead ophthalmic pathologist for the Liverpool Ocular Oncology Centre, which is a referral center receiving patients and tumor specimens from all over the world. She heads the successful Liverpool Ocular Oncology Research Group and has particular interests in the molecular genetics of melanomas and lymphomas. She is guardian of the Liverpool Ocular Oncology Biobank, which is a unique and precious resource of fully annotated ocular tumors and matched blood specimens.

Until April 2014, Prof. Coupland was also lead hematopathologist in the Liverpool-Merseyside Cheshire region, having established the hemato-oncological diagnostic service in September 2011. Further, she oversees the RLBUHT's molecular pathology service, which provides a broad repertoire of cytogenetic, DNA- and RNA-based molecular tests for cancer and noncancer diseases. Prof. Coupland is also director of the North West Cancer Research Centre - UoL and the University's Liverpool Tissue Bank, the oldest cancer biobank in the UK.

Prof. Coupland has extensive committee involvements both nationally and internationally: for example, president of the International Society of Ophthalmic Pathology (2011-present); immediate past president of the European Ophthalmic Oncology Group (2011-2014); and current Anatomy Pathology and Oncology Trustee of ARVO (2013-present). She has published about 200 scientific articles with an H-index of 41 (Google Scholar). Her current grant income totals £2 million as PI and £14 million as Co-I. The latter includes a recent Horizon2020 award involving a European Consortium examining metastatic uveal melanoma.